DDDP and BMY revise drug discovery agreement

3-Dimensional Pharmaceuticals will return $4.5 million to Bristol-Myers out of the

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE